Company / PP&E (Net)
vTv Therapeutics Inc. PP&E (Net) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$28.0K
FY2024
5-year range
$28.0K / $278.0K
FY2020-FY2024
Trend
-76.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 5 consecutive years, from $461,000 in FY2019 to $28,000 in FY2024.
Based on SEC 10-K filings.
$28,000 in FY2024 with a 5-year CAGR of -42.9%.
Declined from $207,000 to $28,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -53.5%
- 5-Year CAGR
- -42.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- vTv Therapeutics Inc.'s pp&e (net) has declined for 5 consecutive years.
- 5-year CAGR of -42.9%, indicating a declining trend.
- In FY2024, pp&e (net) decreased 76.1% year-over-year.
- Peak pp&e (net) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $28.0K | -76.1% |
| FY2023 | $117.0K | -43.5% |
| FY2022 | $207.0K | -25.5% |
| FY2021 | $278.0K | -24.3% |
| FY2020 | $367.0K | -20.4% |
| FY2019 | $461.0K | +558.6% |
| FY2018 | $70.0K | -75.3% |
| FY2017 | $283.0K | -36.3% |
| FY2016 | $444.0K | -28.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026